Foyston, Gordon, & Payne’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $937K | Hold |
|
|||||
|
2021
Q3 | $803K | Hold |
|
|||||
|
2021
Q2 | $701K | Sell |
|
|||||
|
2021
Q1 | $1.54M | Sell |
|
|||||
|
2020
Q4 | $1.59M | Sell |
|
|||||
|
2020
Q3 | $1.59M | Sell |
|
|||||
|
2020
Q2 | $1.5M | Sell |
|
|||||
|
2020
Q1 | $1.38M | Buy |
|
|||||
|
2019
Q4 | $1.33M | Sell |
|
|||||
|
2019
Q3 | $3.04M | Sell |
|
|||||
|
2019
Q2 | $3.08M | Sell |
|
|||||
|
2019
Q1 | $3.21M | Sell |
|
|||||
|
2018
Q4 | $2.84M | Sell |
|
|||||
|
2018
Q3 | $2.93M | Buy |
|
|||||
|
2018
Q2 | $2.84M | Sell |
|
|||||
|
2018
Q1 | $5.25M | Sell |
|
|||||
|
2017
Q4 | $5.88M | Sell |
|
|||||
|
2017
Q3 | $8.26M | Buy |
|
|||||
|
2017
Q2 | $4.91M | Sell |
|
|||||
|
2017
Q1 | $4.02M | Buy |
|
|||||
|
2016
Q4 | $3.37M | Buy |
|